Page last updated: 2024-10-17

aminocaproic acid and Porphyrias

aminocaproic acid has been researched along with Porphyrias in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gorchein, A1

Other Studies

1 other study available for aminocaproic acid and Porphyrias

ArticleYear
Determination of delta-aminolaevulinic acid in biological fluids by gas-liquid chromatography with electron-capture detection.
    The Biochemical journal, 1984, May-01, Volume: 219, Issue:3

    Topics: Aminocaproic Acid; Aminolevulinic Acid; Body Fluids; Chromatography, Gas; Chromatography, Thin Layer

1984